A near full-length open reading frame next generation sequencing assay for genotyping and identification of resistance-associated variants in hepatitis C virus-Reference-Cited by-同舟云学术

A near full-length open reading frame next generation sequencing assay for genotyping and identification of resistance-associated variants in hepatitis C virus

Published:2018-08 Issue: Volume:105 Page:49-56
ISSN:1386-6532
Container-title:Journal of Clinical Virology
language:en
Short-container-title:Journal of Clinical Virology

Author:

Pedersen M.S.^ORCID,Fahnøe U.,Hansen T.A.,Pedersen A.G.,Jenssen H.,Bukh J.^ORCID,Schønning K.^ORCID

Funder

The A.P. Møller Foundation

The Scandinavian Society for Antimicrobial Chemotherapy Foundation

Hvidovre Hospital Research Foundation

Roskilde University

The Capital Region of Denmark’s Research Foundation

Innovation Fund Denmark

Novo Nordisk Foundation

Danish Research Council

Publisher

Elsevier BV

Subject

Infectious Diseases,Virology

Reference44 articles.

1. Replication of hepatitis C virus;Moradpour;Nat. Rev. Microbiol.,2007

2. The history of hepatitis C virus (HCV): Basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control;Bukh;J. Hepatol.,2016

3. Proposed update to the taxonomy of the genera Hepacivirus and Pegivirus within the Flaviviridae family;Smith;J. Gen. Virol.,2016

4. ICTV virus taxonomy profile: flaviviridae;Simmonds;J. Gen. Virol.,2017

5. Hepatitis C virus resistance to direct-acting antiviral drugs in interferon-free regimens;Pawlotsky;Gastroenterology,2016

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-molecule sequencing of the whole HCV genome revealed envelope deletions in decompensated cirrhosis associated with NS2 and NS5A mutations;Journal of Gastroenterology;2024-09-03

2. Pre‐existing, treatment‐specific resistance‐associated substitutions in hepatitis C virus genotype 1 and 3 and viral RNA titers during treatment with direct‐acting antivirals;APMIS;2023-06-25

3. Novel HCV Genotype 4d Infectious Systems and Assessment of Direct-Acting Antivirals and Antibody Neutralization;Viruses;2022-11-15

4. Global evolutionary analysis of chronic hepatitis C patients revealed significant effect of baseline viral resistance, including novel non‐target sites, for DAA‐based treatment and retreatment outcome;Journal of Viral Hepatitis;2020-11-25

5. Full‐length genome sequencing of RNA viruses—How the approach can enlighten us on hepatitis C and hepatitis E viruses;Reviews in Medical Virology;2020-11-22